Direkt zum Inhalt
Merck
  • Metabolic Abnormalities in Erythrocyte Membranes and Liver Tissue Homogenates in Experimental Diabetes Mellitus.

Metabolic Abnormalities in Erythrocyte Membranes and Liver Tissue Homogenates in Experimental Diabetes Mellitus.

Bulletin of experimental biology and medicine (2015-06-23)
N P Mikaelyan, H Z Nguen, A A Terent'ev
ZUSAMMENFASSUNG

Considerable changes in serum lipids and lipoprotein profiles associated with hypertriglyceridemia, hypercholesterolemia, increased VLDL and LDL concentrations, and reduced HDL level occur at the early stages of streptozotocin-induced diabetes (day 7) in rats. The level of saturated palmitic fatty acid increased and the levels of monounsaturated fatty acids decreased at the expense of oleic acid, which considerably differed from changes in these parameters observed in patients with diabetes mellitus. Our findings suggest that changes in the lipid composition and fatty acid pool in erythrocytes and liver homogenates are pro-atherosclerotic already in the early stages of diabetes development.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Cholesterin, Sigma Grade, ≥99%
Sigma-Aldrich
Cholesterin, powder, BioReagent, suitable for cell culture, ≥99%
Sigma-Aldrich
SyntheChol® NS0-Supplement, 500 ×, synthetic cholesterol, animal component-free, sterile-filtered, aqueous solution, suitable for cell culture
Sigma-Aldrich
Cholesterin, from sheep wool, ≥92.5% (GC), powder
SAFC
Cholesterin, from sheep wool, Controlled origin, meets USP/NF testing specifications
Sigma-Aldrich
Cholesterin, from lanolin, ≥99.0% (GC)